Purpose. M DM 2 is an oncogene whose protein product m ay promote tumorigenesis by blocking wild-type p53 tumor suppressor mediated G0/G1 cell cycle arrest, thereby inhibiting repair of damaged DN A prior to cell division. W hile M DM 2 DNA ampli® cation is frequently observed in human sarcoma, the mechanism s linking this ampli® cation to M DM 2 oncoprotein over-production as well as its functional signi® cance have not been well characterized in patients with soft tissue sarcoma. M eth ods. A tissue bank of resected soft tissue sarcomas and autologous normal tissues was assembled; all specimens were snap frozen within 15 m in of resection. DN A and RNA were extracted from tissues using isoamyl alcohol and phenol chloroform extraction methods, respectively; cell lysates were prepared using PBSTDS lysis buffer. DN A and mRNA were con® rmed as being non-degraded and were then examined for M DM 2 DNA ampli® cation (Southern blots) and mRNA over-expression (Northern blots) using actin (DNA) and glyceraldehyde-3-phosphate dehydrogenase (mRNA) as loading controls. The M DM2 protein was examined on Western blots using the M DM 2-speci® c monoclonal antibody IF2 (Oncogene Science, Inc). The presence of p53 DN A and expression of p53 mRNA was examined by rehybridizing the Southern and Northern ® lters using a p53-speci® c cD NA probe. Results. Soft tissue sarcomas and autologous normal tissues were screened for M DM 2 DNA ampli® cation, which was detected in 10 of 30 tumors screened. After screening, there was suf® cient biomaterials from six specimens for subsequent Northern and Western analysis to see whether M DM 2 gene ampli® cation correlated with over-expression of M DM 2 m RNA and MDM 2 protein. In addition, we exam ined whether other mechanisms m ay lead to over-expression of the M DM2 oncoprotein. Several possible mechanisms of MDM2 oncoprotein over-expression were identi® ed. These most comm only included M D M 2 DNA ampli® cation, M DM 2 m RNA over-expression and M DM 2 oncoprotein over-expression. However, some soft tissue sarcoma patient specimens had no evidence of M DM 2 mRNA over-expression yet had M DM2 oncoprotein over-production in the tumor relative to autologous normal tissue, implying possible post-transcriptional regulation. Of functional relevance, M DM 2 oncoprotein over-production by tumors was associated with large decreases in the percentage of cells in the G0/G1 cell cycle interface compared with autologous normal tissue cells. D iscussion. It is likely that there are multiple mechanisms underlying human soft tissue sarcoma MDM 2 oncoprotein over-production. C onsequently, strategies that decrease MDM2 over-production, such as transcriptional repression to inhibit M DM 2 prom oter activity or RNA antisense approaches, may ultimately offer the best therapeutic ef® cacy.
Introduction
T he M D M 2 oncogene codes for a 90-kD a protein m ay be involved in regulation of tum or proliferation via suppression of w ild-type (w t) p53 m ediated G 1 cell cycle checkpoint control.
1,2 MD M 2 can overcom e wt p53 suppression of transfo rmed cell growth, 3 m ost likely by form ing a com plex with wt p53 4 and thereby concealing the wt p53 activation dom ain. 5 Experim entally induced D N A dam age increases levels of M D M 2 m RN A in cells expressing wt p53; 6 wt p53 m ay transcriptionally activate the M DM 2 gene. 7, 8 These interactions suggest an autoregulatory feedback loop in which wt p53 protein regulates the M DM 2 gene at the transcriptional level and M D M 2 protein regulates w t p53 protein at the activity level. 9, 10 This autoregulatory netw ork as elucidated in the above cell line experim entation suggests that the coordinate presence of mutated p53 and M D M 2 would be redundant in suppressing G1 
mRN A analysis
T otal cellular RN A was extracted directly from snap frozen tumor specimens using a guanidinium thiocyanate± hot phenol m ethod as described previously. 31 For N orthern blot analyses, Poly(A 1 ) RN A was prepared by oligo(dT)-cellulose chrom atography, fractionated on 1% denaturing form aldehyde± agarose gels, electrotransferred at 0.6 A to a GeneScreen nylon mem brane (DuPont C o., Boston, M A, U SA) and UV cross-linked with 120 000 m J cm 
D iscussion
W hile M DM 2 gene am pli® cation appears to be a relatively com mon event in soft tissue sarcom a and several other solid m alignancies, the spectrum of involvem ent apparently does not include m edulloblastom a, 33 m elanom a, 34 Ewing' s sarcom a, 35 cervical carcinom a, 36 m yelodysplastic syndrom es, 37 W ilm s' tum or 38 and esophageal carcinom a. 15 Sim ilar post-transcriptional regulatory mechanism s were also identi® ed in studies involving breast carcinom a cell lines conducted by Gudas et al. 42 However, to date, M DM 2 post-transcriptional regulation has not been analyzed in soft tissue sarcom a, perhaps because of the relative rarity of the disease and the dif® culties in extracting m RN A from sarcom a tissues. 30, 43 Several studies have focused on the issue of con- 
